Literature DB >> 11833938

Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture.

V Novaro1, A Colman-Lerner, F V Ortega, A Jawerbaum, D Paz, F Lo Nostro, C Pustovrh, M F Gimeno, E González.   

Abstract

The process of embryo implantation requires extensive remodelling of the endometrial extracellular matrix, a function largely performed by matrix-degrading metalloproteinases (MMPs). In the present study, we used trophoblast cells isolated from human term placentas to study the regulation of MMPs by nitric oxide (NO). Using a combination of zymography, Western blot and indirect immunofluorescence, we showed that MMP-2 and MMP-9 are increased during the conversion from low-motile cytotrophoblast cells to the highly motile and differentiated syncytiotrophoblast multinucleated cells. We also observed an increase in NO production and NO synthase (NOS) expression during this cellular differentiation process. In addition, we demonstrated a positive regulatory role of NO on the activity and protein expression of MMP-2 and MMP-9, because NO donors (NOC-18 and spermine-NONOate) or the NOS substrate (L-arginine) stimulate, whereas NOS inhibitors (N(G)-nitro-L-arginine methyl ester and N(G)-monomethyl-L-arginine) reduce the expression and gelatinolytic activity of MMP-2 and MMP-9 in isolated trophoblast cells. Taken together, these results suggest that, in differentiating trophoblasts, NO regulates the induction of matrix-degrading proteases required for invasion during embryo implantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11833938     DOI: 10.1071/rd01036

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  15 in total

1.  Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta.

Authors:  Jenny Corthorn; Alfredo A Germain; Cecilia Chacón; Sergio Rey; Gloria X Soto; Carlos D Figueroa; Werner Müller-Esterl; Ignacio Duarte; Gloria Valdés
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

Review 2.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

3.  Adrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia.

Authors:  Madhu Chauhan; Meena Balakrishnan; Alex Vidaeff; Uma Yallampalli; Fernando Lugo; Karin Fox; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2016-09-01       Impact factor: 5.958

Review 4.  Mechanism of maternal vascular remodeling during human pregnancy.

Authors:  Yukiyasu Sato; Hiroshi Fujiwara; Ikuo Konishi
Journal:  Reprod Med Biol       Date:  2011-07-16

5.  Potential role of intermedin/adrenomedullin 2 in early embryonic development in rats.

Authors:  Madhu Chauhan; Rebekah Elkins; Meena Balakrishnan; Chandra Yallampalli
Journal:  Regul Pept       Date:  2011-06-02

6.  Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition.

Authors:  Sarah A Hale; Lindsey Weger; Maurizio Mandala; George Osol
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

Review 7.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.

Authors:  Debashree Basudhar; Veena Somasundaram; Graciele Almeida de Oliveira; Aparna Kesarwala; Julie L Heinecke; Robert Y Cheng; Sharon A Glynn; Stefan Ambs; David A Wink; Lisa A Ridnour
Journal:  Antioxid Redox Signal       Date:  2016-09-07       Impact factor: 8.401

8.  Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.

Authors:  Angel Díaz-Lagares; Estibaliz Alegre; Joel LeMaoult; Edgardo D Carosella; Alvaro González
Journal:  Immunology       Date:  2008-09-01       Impact factor: 7.397

Review 9.  Uric acid as a pathogenic factor in preeclampsia.

Authors:  S A Bainbridge; J M Roberts
Journal:  Placenta       Date:  2008-02-21       Impact factor: 3.481

Review 10.  Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

Authors:  Somnath Mukhopadhyay; David A Tulis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.